Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect

Pediatric Cardiology

Volumn 28, Issue 4, 2007, Pages 272-275

  Ozhan, H ^a   Albayrak, S ^a   Uzun, H ^a   Ordu, S ^a   Kaya, A ^a   Yazici, M ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Atrial septal defect; B type natriuretic peptide; Ventricular septal defect

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MALE; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

CHILD, PRESCHOOL; CORONARY CIRCULATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FLUOROIMMUNOASSAY; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 34250862152     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-006-0014-3     Document Type: Article

References (11)

1. Choi BM, Lee KH, Eun BL, et al. (2005) Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115:255-261
2. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS (2005) The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 147:38-42
3. Holmstrom H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90:184-191
4. Jensen KT, Carstens J, Pedersen EB (1998) Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274:F63-F72
5. Muta H, Ishii M, Maeno Y, Akagi T, Kato H (2002) Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 91:649-652
6. Nagaya N, Nishikimi T, Uematsu M, et al. (1998) Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 136:297-301
7. Ootaki Y, Yamaguchi M, Yoshimura N, et al. (2003) Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease. J Thorac Cardiovasc Surg 126:14110-1416
8. Sanders SP, Yeager S, Williams RG (1983) Measurement of systemic and pulmonary blood flow and Qp/Qs ratio using Doppler and two dimensional echocardiography. Am J Cardiol 51:952-956
9. Suda K, Matsumura M, Matsumoto M (2003) Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45:249-254
10. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren D (2004) Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93:340-345
11. Yoshimura M, Yasue H, Okumura K, et al. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87:464-469